IL17A and colitis: After DSS treatment, IL-17RC KO in Tak1ΔM/ΔM mice completely converted the resistant phenotype to the sensitive phenotype (Fig. 5A), suggesting that IL-17RC receptor is required for IL-17A–mediated inhibition of chemokine expression and resistance to DSS-induced colitis.